Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Data Page
  • Published:

Biotech hits regulatory doldrums

Nature Biotechnology volume 23, page 644 (2005)Cite this article

An Erratum to this article was published on 01 July 2005

This article has been updated

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 01 July 2005

    Nat. Biotechnol. 23, 644 (2005) On the x-axis of the graph “Approval times for priority and standard BLAs,” the years should have ranged, from left to right, from 1995 to 2004. In addition, the colors of all but the last number are incorrect. The upper numbers should have been brown and the lower blue.

Authors
  1. Stacy Lawrence
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lawrence, S. Biotech hits regulatory doldrums. Nat Biotechnol 23, 644 (2005). https://doi.org/10.1038/nbt0605-644

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0605-644

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing